BDBM602685 2-[1-(2-Isoindolin-2-yl-3,6- dimethyl-4-oxo-chromen-8- yl)ethylamino]benzoic acid, Isomer 1::US11649227, Example 265::US20230286960, Example 265
SMILES CC(Nc1ccccc1C(O)=O)c1cc(C)cc2c1oc(N1Cc3ccccc3C1)c(C)c2=O
InChI Key InChIKey=JDYCPMDZQGACFN-UHFFFAOYSA-N
Data 4 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 4 hits for monomerid = 602685
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Petra Pharma
US Patent
Petra Pharma
US Patent
Affinity DataIC50: 3.00E+3nMAssay Description:Recombinant, catalytically active human full length PIK3KA Wild-type and H1047R mutant were purchased as 1:1 complex of N-terminal 6× his tagged p110...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [H1047R](Human)
Petra Pharma
US Patent
Petra Pharma
US Patent
Affinity DataIC50: 500nMAssay Description:Recombinant, catalytically active human full length PIK3KA Wild-type and H1047R mutant were purchased as 1:1 complex of N-terminal 6× his tagged p110...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform(Human)
Petra Pharma
US Patent
Petra Pharma
US Patent
Affinity DataIC50: 3.00E+3nMAssay Description:Recombinant, catalytically active human full length PIK3KA Wild-type and H1047R mutant were purchased as 1:1 complex of N-terminal 6×his tagged p110<...More data for this Ligand-Target Pair
TargetPhosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [H1047R](Human)
Petra Pharma
US Patent
Petra Pharma
US Patent
Affinity DataIC50: 500nMAssay Description:Recombinant, catalytically active human full length PIK3KA Wild-type and H1047R mutant were purchased as 1:1 complex of N-terminal 6×his tagged p110<...More data for this Ligand-Target Pair